期刊文献+

左西孟旦在急性心力衰竭治疗中的应用进展 被引量:28

原文传递
导出
摘要 目的:介绍新型药物左西孟旦在急性心力衰竭治疗中的应用进展。方法:根据文献调研,综述左西孟旦的药理学、药动学和临床应用。结果与结论:急性心力衰竭是严重的心血管事件,主要治疗策略是应用静脉利尿药、血管扩张药和正性肌力药物使患者血流动力学稳定,缓解症状。临床上应用的传统正性肌力药缺乏降低远期死亡率的证据,长期应用会增加心肌耗氧量,影响心肌舒张,诱发心律失常,增加患者病死率。左西孟旦作为一种新型Ca2+增敏剂,作用机制独特,增强心肌收缩力的同时不增加细胞内Ca2+浓度,不增加死亡率,为急性失代偿性心力衰竭的治疗提供了理想选择。
作者 孙宝莹
出处 《中国药房》 CAS CSCD 北大核心 2011年第18期1718-1720,共3页 China Pharmacy
  • 相关文献

参考文献13

  • 1急性心力衰竭诊断和治疗指南[J].中华心血管病杂志,2010,38(3):195-208. 被引量:838
  • 2Dec GW. Acute decompensated heart failure: the shrinking role of inotropic therapy[J]. J Am Coll Cardiol, 2005, 46(1):65.
  • 3Endon M.Mechanisms of action of novel cardiotonic agents [J] .J Cardiovasc Pharmacol, 2002,40 (3) : 323.
  • 4Papp Z, Csapo K, Pollesello P, et al.Pharmacological mechanisms contributing to the clinical efficacy of levosimendan[J]. Cardiov Dse Drug Rev, 2005,23 ( 1 ) : 71.
  • 5Grossini E, Molinari C, Caimmi PP, et al.Levosimendan induces NO production through p38 MAPK, ERK and Akt in porcine coronary endothelial cells: role for mitochondrial K(ATP) charmel.[J] BrJPharmacol, 2009 , 156 (2):250.
  • 6Kivikko M, Antila S, Eha J, et al.Pharmacodynamics and Safety of a New Calcium Sensitizer, Levosimendan, and Its Metabolites during an Extendedlnfusion in Patients with Severe Heart Failure[J]. J Clin Pharmacol, 2002, 42 (1):43.
  • 7Follath F, Cleland JG, Just H, et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study) : a randomised double-blind trial[J]. Lancet, 2002,360 (9 328) : 196.
  • 8Moiseyev VS, Poder P, Andrejevs N, et al. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN) [J]. Eur Heart J, 2002, 23 (18):1 422.
  • 9Cleland JG, Ghosh J, Freemantle N, et al.Clinical trials update and cumulative Meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failure[J]. Eur J Heart Fail , 2004 , 6 ( 4 ) :501.
  • 10Packer M, Colueci WS, Fisher L, et al.Development of a comprehensive new end point for the evaluation of new treatments for acute decompensated heart failure:results with levosimendan in the REVIVE 1 study[J].J CardFail, 2003,9(5) :61.

二级参考文献39

  • 1谢洪智,朱文玲.重组人脑利钠肽和硝酸甘油治疗急性失代偿性心力衰竭疗效和安全性的随机、开放、平行对照的多中心临床研究[J].中华心血管病杂志,2006,34(3):222-226. 被引量:228
  • 2中华医学会心血管病学分会 中华心血管病杂志编辑委员会.β肾上腺素能受体阻滞剂在心血管疾病应用的专家共识[J].中华心血管病杂志,2009,37:195-209.
  • 3中华医学会心血管病学分会 中华心血管病杂志编辑委员会.慢性心力衰竭诊断治疗建议.中华心血管病杂志,2007,35(12):1076-1095.
  • 4Nieminen MS, Bohm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26: 384-416.
  • 5Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 : the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC ( HFA ) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J, 2008, 29 : 2388-2442.
  • 6Hunt SA, American College of Cardiology, American Heart Association Task Force on Practice Guidelines ( Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure ). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart fa/lure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol, 2005, 46: e1-e82.
  • 7Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Aduks: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines : developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation, 2009, 119: 1977-2016.
  • 8Liang KV, Williams AW, Greene EL, et al. Acute decompensated heart failure and the cardiorenal syndrome. Crit Care Med, 2008, 36(1 Suppl) : S75-S88.
  • 9Chen D, Assad-Kottner C, Orrego C, et al. Cytokines and acute heart failure. Crit Care Med, 2008, 36(1 Suppl) : S9-S16.
  • 10Chen AA, Wood MJ, Krauser DG, et al. NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy. Eur Heart J, 2006, 27 : 839-845.

共引文献837

同被引文献192

引证文献28

二级引证文献255

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部